These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6212068)

  • 21. Effects of treatment on circadian rhythms of blood pressure.
    Raftery EB; Millar-Craig MW; Mann S; Balasubramanian V
    Biotelem Patient Monit; 1981; 8(1-2):113-20. PubMed ID: 7295917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urapidil in normotensive and spontaneously hypertensive rats: the effects on systemic and regional haemodynamics and cardiac mass.
    Kobrin I; Gallo AJ; Pegram BL; Frohlich ED
    J Hypertens; 1984 Jun; 2(3):317-20. PubMed ID: 6530543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural regression of the vasculature during antihypertensive treatment.
    Jern S; Sivertsson R
    J Clin Hypertens; 1987 Sep; 3(3):355-9. PubMed ID: 3668595
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ask the doctor. How does a beta blocker affect my heart rate and exercise?
    Lee RT
    Harv Heart Lett; 2004 Aug; 14(12):8. PubMed ID: 15326001
    [No Abstract]   [Full Text] [Related]  

  • 26. [[Antihypertensive therapy and organ protection].
    Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
    Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R; Bonhomme MC; Diebold S
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism(s) of systolic blood pressure reduction and drug therapy in hypertension.
    Safar ME
    Hypertension; 2007 Jul; 50(1):167-71. PubMed ID: 17420338
    [No Abstract]   [Full Text] [Related]  

  • 29. Regression of cardiac hypertrophy and night-time blood pressure reduction.
    Muiesan ML; Rizzoni D; Zulli R; Calebich S; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S300-1. PubMed ID: 8158395
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension.
    Park JB; Intengan HD; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):40-5. PubMed ID: 11967798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic and therapeutic problems in hypertensive heart disease].
    Strauer BE
    Z Kardiol; 1993; 82 Suppl 4():17-24. PubMed ID: 8147058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldosterone antagonist therapy in resistant hypertension.
    Zannad F
    J Hypertens; 2007 Apr; 25(4):747-50. PubMed ID: 17351364
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of non-steroidal anti-inflammatory drugs on blood pressure.
    Spence JD
    J Hypertens; 2007 Jan; 25(1):248; author reply 248-9. PubMed ID: 17143199
    [No Abstract]   [Full Text] [Related]  

  • 34. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
    Phipps JA; Wilkinson-Berka JL; Fletcher EL
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):927-34. PubMed ID: 17251496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should diuretics be combined with calcium antagonists?
    Lazar AI
    J Assoc Physicians India; 1996 Jan; 44(1):71-2. PubMed ID: 8773109
    [No Abstract]   [Full Text] [Related]  

  • 38. Early structural changes in hypertension: pathophysiology and clinical consequences.
    Folkow B
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S1-6. PubMed ID: 7507535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current role of diuretics in antihypertensive therapy].
    Rodrigues CI; Ribeiro AB
    AMB Rev Assoc Med Bras; 1987; 33(7-8):140-3. PubMed ID: 3502496
    [No Abstract]   [Full Text] [Related]  

  • 40. [The significance of left cardiac hypertrophy in arterial hypertension].
    Riegger AJ
    Dtsch Med Wochenschr; 1986 Sep; 111(38):1448-9. PubMed ID: 2944734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.